WWM
BSX icon

Western Wealth Management’s Boston Scientific BSX Stock Holding History

Western Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$596K Sell
13,974
-11,126
-44% -$604K 0.02% 628
2026
Q1 		$1.58M Buy
25,100
+171
+0.7% +$13.7K 0.06% 326
2025
Q4 		$2.38M Buy
24,929
+30
+0.1% +$2.94K 0.11% 188
2025
Q3 		$2.43M Buy
24,899
+1,309
+6% +$136K 0.13% 156
2025
Q2 		$2.53M Buy
23,590
+3,338
+16% +$338K 0.15% 137
2025
Q1 		$2.04M Sell
20,252
-8
-0% -$806 0.14% 154
2024
Q4 		$1.81M Buy
20,260
+1,678
+9% +$148K 0.1% 212
2024
Q3 		$1.56M Sell
18,582
-44
-0.2% -$3.47K 0.09% 231
2024
Q2 		$1.43M Buy
18,626
+941
+5% +$68.9K 0.11% 167
2024
Q1 		$1.21M Buy
17,685
+757
+4% +$48.7K 0.09% 201
2023
Q4 		$979K Buy
16,928
+1,043
+7% +$55.7K 0.07% 282
2023
Q3 		$839K Buy
15,885
+1,489
+10% +$78.1K 0.07% 284
2023
Q2 		$779K Buy
14,396
+1,407
+11% +$73.5K 0.07% 283
2023
Q1 		$650K Buy
12,989
+563
+5% +$26.5K 0.06% 313
2022
Q4 		$575K Sell
12,426
-12,585
-50% -$545K 0.06% 313
2022
Q3 		$973K Buy
25,011
+409
+2% +$16.4K 0.06% 312
2022
Q2 		$918K Sell
24,602
-98
-0.4% -$3.99K 0.05% 322
2022
Q1 		$1.09M Buy
24,700
+11,824
+92% +$512K 0.05% 321
2021
Q4 		$541K Buy
+12,876
New +$541K 0.05% 308
2021
Q2 		$406K Buy
9,577
+376
+4% +$15.8K 0.04% 411
2021
Q1 		$356K Sell
9,201
-240
-3% -$9.08K 0.05% 369
2020
Q4 		$339K Sell
9,441
-78
-0.8% -$2.81K 0.05% 326
2020
Q3 		$364K Buy
9,519
+351
+4% +$13.5K 0.06% 294
2020
Q2 		$322K Sell
9,168
-108
-1% -$3.89K 0.06% 300
2020
Q1 		$307K Buy
9,276
+462
+5% +$18K 0.07% 266
2019
Q4 		$399K Sell
8,814
-279
-3% -$11.7K 0.06% 266
2019
Q3 		$366K Sell
9,093
-93
-1% -$3.94K 0.08% 257
2019
Q2 		$393K Buy
9,186
+528
+6% +$20.3K 0.05% 261
2019
Q1 		$333K Sell
8,658
-325
-4% -$12.4K 0.07% 264
2018
Q4 		$319K Buy
+8,983
New +$326K 0.09% 242

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Western Wealth Management's BSX Position: Q2 2026 in Review

Western Wealth Management reduced its Boston Scientific (BSX) stake by 44% in Q2 2026, selling an estimated $604K and leaving 13,974 shares worth $596K. The position accounts for 0.02% of the portfolio, ranked #628.

Western Wealth Management first reported a position in BSX in Q4 2018 and has held it in 30 quarters since. The position peaked at $2.53M in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Western Wealth Management held 13,974 shares of Boston Scientific worth $596K as of Q2 2026.
  • Western Wealth Management sold 11,126 Boston Scientific shares in Q2 2026, an estimated $604K.
  • Boston Scientific made up 0.02% of Western Wealth Management's portfolio in Q2 2026, its #628 holding.
  • Western Wealth Management first reported a position in Boston Scientific in Q4 2018 and has held it in 30 quarters since.
  • Western Wealth Management's Boston Scientific position peaked at $2.53M in Q2 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Western Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.